(Q72450632)
Statements
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors (English)
Sparano JA
Fisher RI
Weiss GR
Margolin K
Aronson FR
Hawkins MJ
Atkins MB
Gaynor ER